having two or three double bonds between ring members or between ring members and non-ring members

Industry

CPC
C07D263/30

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07DHETEROCYCLIC COMPOUNDS C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Current Industry

C07D263/30having two or three double bonds between ring members or between ring members and non-ring members

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods of treating cardiac fibrosis with ifetroban
- Patent number 12,161,632
- Issue date Dec 10, 2024
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of treating cardiac fibrosis with ifetroban
- Patent number 10,925,860
- Issue date Feb 23, 2021
- Cumberland Pharmaceuticals, Inc.
- Leo Pavliv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of treating cardiac fibrosis with ifetroban
- Patent number 10,583,126
- Issue date Mar 10, 2020
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonamides as GPR40- and GPR120-agonists
- Patent number 10,508,090
- Issue date Dec 17, 2019
- DOMPE' FARMACEUTICI S.P.A.
- Maria De Pizzol
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of treating cardiac fibrosis with ifetroban
- Patent number 10,314,824
- Issue date Jun 11, 2019
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl lactam kinase inhibitors
- Patent number 10,253,027
- Issue date Apr 9, 2019
- Bristol-Myers Squibb Company
- Richard A. Hartz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods of treating cardiac fibrosis with ifetroban
- Patent number 10,016,399
- Issue date Jul 10, 2018
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
5,5-bicyclic oxazole orexin receptor antagonists
- Patent number 9,987,255
- Issue date Jun 5, 2018
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic inhibitors of hydroxysteroid dehydrogenases
- Patent number 8,765,788
- Issue date Jul 1, 2014
- Amgen Inc.
- Jay P. Powers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Large conductance calcium-activated K channel opener
- Patent number 7,759,373
- Issue date Jul 20, 2010
- Mitsubishi Tanabe Pharma Corporation
- Mitsuya Hongu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serotonin 5-HT3 receptor partial activator
- Patent number 6,867,226
- Issue date Mar 15, 2005
- Meiji Seika Kaisha, Ltd.
- Yasuo Sato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serotonin 5-HT3 receptor partial activator
- Patent number 6,552,057
- Issue date Apr 22, 2003
- Meiji Seika Kaisha, Ltd.
- Yasuo Sato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serotonin 5-HT3 receptor partial activator
- Patent number 6,333,328
- Issue date Dec 25, 2001
- Meiji Seika Kaisha, Ltd.
- Yasuo Sato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serotonin 5-HT3, receptor partial activator
- Patent number 6,297,246
- Issue date Oct 2, 2001
- Meiji Seika Kaisha Ltd.
- Yasuo Sato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serotonin 5-HT.sub.3 receptor partial activator
- Patent number 6,037,342
- Issue date Mar 14, 2000
- Meiji Seika Kaisha, Ltd.
- Yasuo Sato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3819355
- Patent number 3,819,355
- Issue date Jun 25, 1974
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3751239
- Patent number 3,751,239
- Issue date Aug 7, 1973
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3723452
- Patent number 3,723,452
- Issue date Mar 27, 1973
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3661991
- Patent number 3,661,991
- Issue date May 9, 1972
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
- Publication number 20250049764
- Publication date Feb 13, 2025
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
- Publication number 20230270726
- Publication date Aug 31, 2023
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NAMPT MODULATORS
- Publication number 20230133132
- Publication date May 4, 2023
- Cytokinetics, Inc.
- Antonio ROMERO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
- Publication number 20210137895
- Publication date May 13, 2021
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
- Publication number 20200155512
- Publication date May 21, 2020
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
- Publication number 20190247364
- Publication date Aug 15, 2019
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
- Publication number 20180344704
- Publication date Dec 6, 2018
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5,5-Bicyclic Oxazole Orexin Receptor Antagonists
- Publication number 20170368035
- Publication date Dec 28, 2017
- Scott D. Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
- Publication number 20170258771
- Publication date Sep 14, 2017
- Cumberland Pharmaceuticals Inc.
- Leo Pavliv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GGA DERIVATIVES
- Publication number 20150133431
- Publication date May 14, 2015
- Coyote Pharmaceuticals, Inc.
- Gary C. Look
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC INHIBITORS OF HYDROXYSTEROID DEHYDROGENASES
- Publication number 20100280073
- Publication date Nov 4, 2010
- Amgen Inc.
- Jay P. Powers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER
- Publication number 20100256165
- Publication date Oct 7, 2010
- Mitsuya Hongu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Large conductance calcium-activated k channel opener
- Publication number 20040127527
- Publication date Jul 1, 2004
- Mitsuya Hongu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Serotonin 5-HT3 receptor partial activator
- Publication number 20030013730
- Publication date Jan 16, 2003
- MEIJI SEIKA KAISHA, LTD
- Yasuo Sato
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Serotonin 5-HT, receptor partial activator
- Publication number 20010016579
- Publication date Aug 23, 2001
- Yasuo Sato
- C07 - ORGANIC CHEMISTRY

having two or three double bonds between ring members or between ring members and non-ring members

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Compositions and methods of treating cardiac fibrosis with ifetroban

Compositions and methods of treating cardiac fibrosis with ifetroban

Compositions and methods of treating cardiac fibrosis with ifetroban

Sulfonamides as GPR40- and GPR120-agonists

Compositions and methods of treating cardiac fibrosis with ifetroban

Aryl lactam kinase inhibitors

Compositions and methods of treating cardiac fibrosis with ifetroban

5,5-bicyclic oxazole orexin receptor antagonists

Tricyclic inhibitors of hydroxysteroid dehydrogenases

Large conductance calcium-activated K channel opener

Serotonin 5-HT3 receptor partial activator

Serotonin 5-HT3 receptor partial activator

Serotonin 5-HT3 receptor partial activator

Serotonin 5-HT3, receptor partial activator

Serotonin 5-HT.sub.3 receptor partial activator

3819355

3751239

3723452

3661991

Patents Applicationslast 30 patents

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

NAMPT MODULATORS

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

5,5-Bicyclic Oxazole Orexin Receptor Antagonists

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

GGA DERIVATIVES

TRICYCLIC INHIBITORS OF HYDROXYSTEROID DEHYDROGENASES

LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER

Large conductance calcium-activated k channel opener

Serotonin 5-HT3 receptor partial activator

Serotonin 5-HT, receptor partial activator